Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-12-13 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award +17,500 35,765
2016-12-13 Doberstein Stephen K SVP & Chief Scientific Officer Grant or award · Stock Option +43,750 43,750
2016-12-07 ROBIN HOWARD W President & CEO Exercise or conversion +87,500 $4.65 $407K 210,408
2016-12-07 ROBIN HOWARD W President & CEO Sale −87,500 $12.24 $1.1M 122,908
2016-12-07 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −87,500 175,000
2016-11-17 ROBIN HOWARD W President & CEO Exercise or conversion +87,500 $4.65 $407K 210,408
2016-11-17 ROBIN HOWARD W President & CEO Sale −87,500 $13.87 $1.2M 122,908
2016-11-17 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −87,500 262,500
2016-11-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −1,986 $13.96 $28K 42,102
2016-11-16 ROBIN HOWARD W President & CEO Sale −5,958 $13.96 $83K 122,908
2016-11-16 Nicholson John SVP & Chief Operating Officer Sale −1,654 $13.96 $23K 120,326
2016-11-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −1,654 $13.96 $23K 51,129
2016-11-16 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −1,654 $13.96 $23K 50,343
2016-11-16 Gergel Ivan P. SVP & Chief Medical Officer Sale −848 $13.96 $12K 26,479
2016-11-16 Doberstein Stephen K SVP & Chief Scientific Officer Sale −670 $13.96 $9K 18,265
2016-10-24 GREER R SCOTT Director Purchase +15,000 $13.50 $203K 121,333
2016-10-04 ROBIN HOWARD W President & CEO Exercise or conversion +87,500 $4.65 $407K 216,366
2016-10-04 ROBIN HOWARD W President & CEO Sale −87,500 $17.06 $1.5M 128,866
2016-10-04 ROBIN HOWARD W President & CEO Exercise or conversion · Stock Option −87,500 350,000
2016-09-23 WHITFIELD ROY A Director Exercise or conversion +15,000 $5.15 $77K 53,000

Page 47 of 55 · 1,088 trades